US 11,672,938 B1
Start-up protocols for nitric oxide delivery device
David H. Fine, Cocoa Beach, FL (US); Edward Bromberg, Orlando, FL (US); Ryan Denton, Titusville, FL (US); Jason White, Cocoa, FL (US); Lucas G. Gamero, Oviedo, FL (US); Bryan Johnson, Orlando, FL (US); Gregory Vasquez, Cocoa, FL (US); and Doug Sonosky, Cocoa, FL (US)
Assigned to VERO Biotech LLC, Atlanta, GA (US)
Filed by VERO Biotech LLC, Atlanta, GA (US)
Filed on Jul. 16, 2019, as Appl. No. 16/513,312.
Claims priority of provisional application 62/699,791, filed on Jul. 18, 2018.
Int. Cl. A61M 16/12 (2006.01); A61M 16/00 (2006.01); A61M 16/06 (2006.01); A61M 16/10 (2006.01)
CPC A61M 16/122 (2014.02) [A61M 16/0057 (2013.01); A61M 16/0666 (2013.01); A61M 2016/1025 (2013.01); A61M 2202/0208 (2013.01); A61M 2202/0275 (2013.01); A61M 2205/15 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/6018 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A method, comprising:
coupling a cassette configured to provide NO gas to a console containing a pump and a first flow sensor, the cassette coupled to the console such that the first flow sensor is disposed between the cassette and the pump;
closing an output solenoid that is disposed after the cassette, the output solenoid, when open, configured to allow gas, including NO gas, to be conveyed to a patient, closing the output solenoid configured to place the cassette in fluid communication with a second flow sensor disposed between the cassette and an exhaust port;
activating the pump; and
leak testing the cassette by comparing a flow rate measured by the first flow sensor to a flow rate measured by a second flow sensor.